Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind placebo-controlled randomized trial of Z-100 in cervical cancer with radiation therapy
jRCT2080220032Phase 3
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cervical Cancer (CC) comparing Z-100 + radiation therapy with Placebo + radiation therapy (2 arms).
02
Drugs
Z-100
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCT2080220032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220032.